NIH-funded Research Findings
Read some of the extensive research about NODA’s assessment protocol and technology
NODA is an evidence-based Autism diagnostic service platform that has been brought to market to address some of the challenges with early diagnosis. Current challenges include the lack of access to professionals, long waiting periods, earlier detection, clinical appointment scheduling and costs. NODA has been commercially developed through a $2.7 Million dollar NIMH-funded series of research studies that included Georgia Tech, Behavior Imaging and the Southwest Autism Research and Resource Center.
NODA is market proven for patients and providers. We are implementing more pilot programs. If you are interested in a presentation or call to learn more just email us here: noda@54.162.200.67
Read some of the extensive research about NODA’s assessment protocol and technology
Our implementation with PCH included 3 pieces:
See the PCH newsletter announcing and explaining the partnership. Organizations must communicate the importance, value, and details of implementing NODA to the doctors and professionals who interface with patients and work with Autism every day.
See PCH’s page on their autism program. Next PCH added NODA as one of the tools they use with patients. Patients can now learn about the NODA option and use it in their relationship with PCH.
See our signup page with a special tab for PCH patients in Arizona. Finally, we add a special gateway for partners so that doctors, specialists, and caregivers all have the proper level of access to the technology.